Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2012. The report details a specific share repurchase transaction executed on August 22, 2012, pursuant to shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,400,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,457 pence per share; lowest price paid was 1,440 pence per share.
- Treasury Holdings (Settled): 491,782,927 shares (8.99% of total issued share capital).
- Treasury Holdings (Including Unsettled): 494,658,927 shares (9.93% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,980,269,941 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,400,000 shares for Treasury. Consequently, the percentage of shares held in Treasury increased to 9.93% of total voting rights when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (491,782,927 settled) against the company's latest capitalization table.
- Confirm the calculation of total voting rights (4,980,269,941 shares in issue) for disclosure threshold assessments.
- Review the remaining authority under the May 3, 2012 shareholder mandate for future repurchases.
- Note that this filing does not contain financial performance metrics; refer to the most recent Form 20-F or interim results for revenue and profit data.